GSK Investigational Site

Warren, Michigan 48093

0 studies enrolling now · 6 studies all time

What they study most

Asthma, Deep Vein Thrombosis, Fibrillation, Atrial, Irritable Bowel Syndrome (IBS), Irritable Colon, Neoplasms, Breast, Pulmonary Embolism, Venous Thromboembolism

Studies at this site

• A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma — Running, not enrolling
• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma — Running, not enrolling
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
• Treatment With Pazopanib for Neoadjuvant Breast Cancer — Completed